Evidence mapPaperPMID 40720603Full record

ReviewACS nano2025

Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis.

Hai Linh Tran, Wenshu Zheng, David A Issadore, Hyungsoon Im, Yoon-Kyoung Cho, Yuanqing Zhang, Dingbin Liu, Yang Liu, Bo Li, Fei Liu and 15 more

Abstract readReview
In one paragraph

Review in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Strategies for Multiplexing Plasmonic Biosensing.Sensors (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Review
  7. EpCAMAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Hai Linh TranCenter for Cellular and Molecular Diagnostics and Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.
Wenshu ZhengCenter for Cellular and Molecular Diagnostics and Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.
David A IssadoreDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0002-5461-8653
Hyungsoon ImDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States.ORCID 0000-0002-0626-1346
Yoon-Kyoung ChoDepartment of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea.ORCID 0000-0001-6423-1834
Yuanqing ZhangSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong 510006, China.ORCID 0000-0002-8761-5328
Dingbin LiuState Key Laboratory of Medicinal Chemical Biology, Research Center for Analytical Sciences, Tianjin Key Laboratory of Molecular Recognition and Biosensing, College of Chemistry, Nankai University, Tianjin 300071, China.ORCID 0000-0003-4153-9822
Yang LiuDepartment of Hepatobiliary Cancer, Liver Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.ORCID 0000-0001-6450-9509
Bo LiDepartment of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P. R. China.ORCID 0000-0002-6129-321X
Fei LiuDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.ORCID 0000-0001-5259-5753
David Tai Wai WongSchool of Dentistry, University of California, Los Angeles, California 90095, United States.
Jiashu SunBeijing Engineering Research Center for BioNanotechnology, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing 100190, China.ORCID 0000-0003-4255-6202
Kun QianState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering and Institute of Medical Robotics, Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, PR China.ORCID 0000-0003-1666-1965
Mei HeDepartment of Pharmaceutics, College of Pharmacy; University of Florida, Gainesville, Florida 32611, United States.ORCID 0000-0001-5316-9326
Meihua WanDepartment of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 61004, China.ORCID 0000-0002-1237-9455
Yong ZengDepartment of Chemistry, University of Florida, Gainesville, Florida 32611, United States.
Ke ChengDepartment of Biomedical Engineering, Columbia University, New York, New York 10027, United States.ORCID 0000-0001-7082-6893
Tony Jun HuangDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, North Carolina 27708, United States.ORCID 0000-0003-1205-3313
Daniel T ChiuDepartments of Chemistry and Bioengineering, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0003-2964-9578
Luke P LeeInstitute of Quantum Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID 0000-0002-1436-4054
Lei ZhengGuangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510378, China.ORCID 0000-0003-2576-8780
Andrew K GodwinDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0002-3987-9580
Raghu KalluriDepartment of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States.ORCID 0000-0002-2190-547X
Steven A SoperCenter of BioModular Multiscale Systems for Precision Medicine (CBM2), University of Kansas, Lawrence, Kansas 66045, United States.ORCID 0000-0002-8292-7058
Tony Y HuCenter for Cellular and Molecular Diagnostics and Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.ORCID 0000-0002-5166-4937

Funding

A nanopore biosensor for leveling Mtb antigens in bloodR01AI144168 · NIAID · TULANE UNIVERSITY OF LOUISIANA · 2022 to 2025
$1.5M
Direct quantitation of the circulating Mtb-peptidome for pediatric TB managementR01HD090927 · NICHD · TULANE UNIVERSITY OF LOUISIANA · 2021 to 2025
$1.0M
CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary diseaseR01AI177986 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$743k
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in bloodR01AI175618 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$722k
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPRR01AI174964 · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2025 to 2025
$719k
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHPR01HD103511 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$709k
CRISPR-TB for pediatric TB diagnosis and treatment responseR01AI179714 · UNIVERSITY OF WASHINGTON · 2025 to 2025
$704k
Diagnostic Innovations for Pediatric Tuberculosis in BoliviaR01AI173021 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$690k
NCI NIH HHS U01 CA252965NIAID NIH HHS R01 AI144168NIAID NIH HHS R01 AI173021NIAID NIH HHS R01 AI174964NIAID NIH HHS R01 AI175618NIAID NIH HHS R01 AI177986NIAID NIH HHS R01 AI179714NICHD NIH HHS R01 HD090927NICHD NIH HHS R01 HD103511NINDS NIH HHS R21 NS130542
6 · The paper itself

Abstract

Extracellular vesicles (EVs) play a crucial role in intercellular communication, signaling pathways, and disease pathogenesis by transporting biomolecules such as DNA, RNA, proteins, and lipids derived from their cells of origin, and they have demonstrated substantial potential in clinical applications. Their clinical significance underscores the need for sensitive methods to fully harness their diagnostic potential. In this comprehensive review, we explore EV heterogeneity related to biogenesis, structure, content, origin, sample type, and function roles; the use of EVs as disease biomarkers; and the evolving landscape of EV measurement for clinical diagnostics, highlighting the progression from bulk measurement to single vesicle analysis. This review covers emerging technologies such as single-particle tracking microscopy, single-vesicle RNA sequencing, and various nanopore-, nanoplasmonic-, immuno-digital droplet-, microfluidic-, and nanomaterial-based techniques. Unlike traditional bulk analysis methods, these methods contribute uniquely to EV characterization. Techniques like droplet-based single EV-counting enzyme-linked immunosorbent assays (ELISA), proximity-dependent barcoding assays, and surface-enhanced Raman spectroscopy further enhance our ability to precisely identify biomarkers, detect diseases earlier, and significantly improve clinical outcomes. These innovations provide access to intricate molecular details that expand our understanding of EV composition, with profound diagnostic implications. This review also examines key research challenges in the field, including the complexities of sample analysis, technique sensitivity and specificity, the level of detail provided by analytical methods, and practical applications, and we identify directions for future research. This review underscores the value of advanced EV analysis methods, which contribute to deep insights into EV-mediated pathological diversity and enhanced clinical diagnostics.

Indexed as

Extracellular VesiclesAnimalsBiomarkersHumansBiomarkersanalytical techniquesbiomarkersdiagnosticsextracellular vesicles (EVs)single EV analysis

Identifiers

PMID40720603
PMCPMC12356129

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.